Discngine Labs: Virtual Reality for Structure-Based Drug Discovery
Ever wondered how Virtual Reality for Drug Design looks like in practice?
In the second session of our Discngine Labs, they host industry experts Wilian Cortopassi and Dr. Rishi Gupta from Novartis Institutes for BioMedical Research (NIBR) will present the “NIBR”Verse: the multidimensional space that brings together data and peers from all over the world in a single (virtual) place for effective collaborations in structure-based drug design.
The presentation will be followed by the panel discussion on the current and future opportunities of Virtual Reality for Drug Discovery. Steve McCloskey, from the leading VR software company Nanome, will chair the discussion where industry experts and early adopters will share their thoughts and experiences on the topic.
Recording with video here:
https://www.discngine.com/event/2022/06/23/discngine-labs-virtual-reality-for-collaborative-sbdd
Discngine Labs: Virtual Reality for Structure-Based Drug Discovery
Ever wondered how Virtual Reality for Drug Design looks like in practice?
In the second session of our Discngine Labs, they host industry experts Wilian Cortopassi and Dr. Rishi Gupta from Novartis Institutes for BioMedical Research (NIBR) will present the “NIBR”Verse: the multidimensional space that brings together data and peers from all over the world in a single (virtual) place for effective collaborations in structure-based drug design.
The presentation will be followed by the panel discussion on the current and future opportunities of Virtual Reality for Drug Discovery. Steve McCloskey, from the leading VR software company Nanome, will chair the discussion where industry experts and early adopters will share their thoughts and experiences on the topic.
Recording with video here:
https://www.discngine.com/event/2022/06/23/discngine-labs-virtual-reality-for-collaborative-sbdd